Anadys Looks To Head Of Class In HCV Polymerase Inhibitors With Setrobuvir

Biotech believes strong safety profile and resistance to viral breakthrough could move setrobuvir past Pharmasset's PSI-7977 and other polymerase inhibitors in development in hepatitis C.